Share: Facebook Twitter LinkedIn
Activity Provided By:

Rockpointe

Achieving New Treatment Goals in Multiple Sclerosis: Strategies for Initial Treatment Selection and Patient Engagement

Access Activity

Overview / Abstract:

The clinical benefits of early, aggressive treatment in MS have been demonstrated via slower progression of disease and improved patient quality of life. Disease-free status, or “no evidence of disease activity” (NEDA), is now a realistic treatment goal. However, with 15 current FDA-approved disease-modifying therapies (DMTs) available, it is challenging to personalize selection of the optimal agent for each patient.

Achieving New Treatment Goals in Multiple Sclerosis: Strategies for Initial Treatment Selection and Patient Engagement will provide clinicians with current evidence on biomarker development, comparative treatment effectiveness, monitoring, and maintenance regimens. Participants will explore safety and efficacy data for current and emerging DMTs and NEDA treatment goals. Because of the long-term nature of MS management, effective patient engagement is crucial to achieve the best possible outcomes. The activity will also provide physicians with strategies to foster patient engagement within the time constraints of the typical patient visit.

EDUCATIONAL OBJECTIVES - At the conclusion of this activity, participants should be able to demonstrate the ability to:

- Recognize the benefits of starting an optimal DMT early enough to achieve the new treatment goal of “no evidence of disease activity” (NEDA)
- Apply current evidence to select a personalized disease modifying treatment approach with appropriate modifications based on disease activity
- Implement practical strategies for improving patient engagement in management plans

Expiration

Jul 12, 2019

Discipline(s)

Physician CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

Jointly provided by PCME, CMSC, and Rockpointe. In collaboration with Health Union

Accreditation

AACME - 1.00 AMA PRA Category 1 Credit™; CMSC - 1.0 credit of continuing nursing education

Presenters / Authors / Faculty

Alina Ahsan
MS Community Manager
Health Union, LLC
MultipleSclerosis.net
Philadelphia, PA

Laura Kolaczkowski
Patient Advocate
MultipleSclerosis.net
Dayton, OH

Sponsors / Supporters / Grant Providers

This program was supported by an educational grant from Sanofi Genzyme.

Keywords / Search Terms

Rockpointe Multiple Sclerosis, MS, Neurology, CME, Free CME, Continuing Medical Education, CME Webcourse, Primary Care, Primary Care Provider, On-Demand CME Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map